DYRK1B expression is increased in quiescent cells and inhibition of DYRK1B can sensitize quiescent pancreatic and ovarian carcinoma cell lines to DNA damaging agents18, 19 and quiescent GIST cells to imatinib.11 The gene discussed is DYRK1B; the disease is gastrointestinal stromal tumor.